for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Jazz Pharma Submits New Drug Application For Solriamfetol (JZP-110)

Dec 21 (Reuters) - Jazz Pharmaceuticals Plc:

* JAZZ PHARMACEUTICALS SUBMITS NEW DRUG APPLICATION FOR SOLRIAMFETOL (JZP-110) FOR EXCESSIVE SLEEPINESS ASSOCIATED WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNEA

* JAZZ PHARMACEUTICALS PLC - SUBMISSION OF NDA TO U.S. FDA SEEKING MARKETING APPROVAL FOR SOLRIAMFETOL Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up